KOTAI Biotechnologies
Tokyo, Japan· Est.
KOTAI Biotechnologies develops innovative antibody drugs using its proprietary cell-free protein synthesis and discovery platform.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
KOTAI Biotechnologies develops innovative antibody drugs using its proprietary cell-free protein synthesis and discovery platform.
AntibodiesBiologics